Form 4: Walgreens Boots Alliance Executive Mary Langowski Reports Acquisition of Common Stock

Sentiment:

SEC Form 4 Filing


Mary Langowski, EVP and President of U.S. Healthcare at Walgreens Boots Alliance, reports acquiring common stock through a restricted stock unit award.

Summary

  • On November 1, 2024, Mary Langowski, EVP and President of U.S. Healthcare at Walgreens Boots Alliance, acquired common stock of the company.
  • The acquisition was through a restricted stock unit award granted under the Walgreens Boots Alliance, Inc. 2021 Omnibus Incentive Plan.
  • Langowski acquired 256,684 shares at a price of $0.
  • Following the transaction, Langowski beneficially owns 519,600 shares of Walgreens Boots Alliance, Inc.
  • The restricted stock units vest in one-third increments on each of the first, second, and third anniversaries of the grant date (November 1, 2024), subject to certain conditions.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock acquisition by an executive, which doesn't inherently indicate positive or negative sentiment about the company's prospects.

Positives

  • The acquisition of shares by a high-ranking executive may signal confidence in the company's future performance.

Future Outlook

The restricted stock units vest over three years, incentivizing the executive to remain with the company and contribute to its success.

Industry Context

Executive stock ownership is a common practice in publicly traded companies to align management's interests with those of shareholders. This filing provides transparency into the executive's stake in the company.

Comparison to Industry Standards

  • Executive compensation packages, including stock options and restricted stock units, are standard practice among large corporations like Walgreens Boots Alliance.
  • Comparing Langowski's stock ownership and compensation structure to those of executives at similar companies like CVS Health or UnitedHealth Group would provide a benchmark for assessing its competitiveness and alignment with industry norms.

Stakeholder Impact

  • Shareholders may view the increased stock ownership of a key executive as a positive sign, aligning management's interests with their own.

Key Dates

DateDescription
11/01/2024Date of the transaction (acquisition of common stock).
11/01/2025First vesting date for one-third of the restricted stock units.
11/01/2026Second vesting date for one-third of the restricted stock units.
11/01/2027Third vesting date for one-third of the restricted stock units.
11/05/2024Date of the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.